Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Bergot

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
The European Respiratory Journal|March 19, 2016
Initial dual oral combination therapy in pulmonary arterial hypertensionOlivier Sitbon, Caroline Sattler, Laurent Bertoletti, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
The European Respiratory Journal|December 22, 2022
Cytokines as prognostic biomarkers in pulmonary arterial hypertensionAthénaïs Boucly, Ly Tu, Christophe Guignabert, et al.
Translational Oncology|September 6, 2025
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trialGuénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, et al.
International Journal of Cancer|March 9, 2022
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trialElodie Maille, Jérôme Levallet, Fatéméh Dubois, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2023
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trialGuénaëlle Levallet, Fatéméh Dubois, Nicolas Elie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 24, 2015
Severe hematologic complications after lung transplantation in patients with telomerase complex mutationsRaphael Borie, Caroline Kannengiesser, Sandrine Hirschi, et al.
BMJ Open Respiratory Research|June 5, 2021
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundanceMuriel Fartoukh, Alexandre Demoule, Olivier Sanchez, et al.
The European Respiratory Journal|April 24, 2012
Pulmonary hypertension associated with benfluorex exposureLaurent Savale, Marie-Camille Chaumais, Vincent Cottin, et al.
British Journal of Cancer|February 12, 2019
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trialElodie Maille, Solenn Brosseau, Vincent Hanoux, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
The European Respiratory Journal|March 19, 2016
Initial dual oral combination therapy in pulmonary arterial hypertensionOlivier Sitbon, Caroline Sattler, Laurent Bertoletti, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
The European Respiratory Journal|December 22, 2022
Cytokines as prognostic biomarkers in pulmonary arterial hypertensionAthénaïs Boucly, Ly Tu, Christophe Guignabert, et al.
Translational Oncology|September 6, 2025
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trialGuénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, et al.
International Journal of Cancer|March 9, 2022
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trialElodie Maille, Jérôme Levallet, Fatéméh Dubois, et al.
Lung Cancer (Amsterdam, Netherlands)|July 2, 2023
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trialGuénaëlle Levallet, Fatéméh Dubois, Nicolas Elie, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 24, 2015
Severe hematologic complications after lung transplantation in patients with telomerase complex mutationsRaphael Borie, Caroline Kannengiesser, Sandrine Hirschi, et al.
BMJ Open Respiratory Research|June 5, 2021
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundanceMuriel Fartoukh, Alexandre Demoule, Olivier Sanchez, et al.
The European Respiratory Journal|April 24, 2012
Pulmonary hypertension associated with benfluorex exposureLaurent Savale, Marie-Camille Chaumais, Vincent Cottin, et al.
British Journal of Cancer|February 12, 2019
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trialElodie Maille, Solenn Brosseau, Vincent Hanoux, et al.
Pageof 10